Patent · US Active

Use of VEGFR-3 inhibitors for treating hepatocellular carcinoma

US9376432B2 · kind B2 · utility

0Cited by
2References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 2013
Grant dateJun 28, 2016
Priority date—
Expiry dateJul 16, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention is related to the use of inhibitors of vascular endothelial growth factor receptor 3 for treating hepatocellular carcinoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.